Publication: Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
Program
KU-Authors
KU Authors
Co-Authors
Nomak, G.
Oksuzoglu, B.
Senturk, R.
Eralp, Y.
Nomak, H.
Sanyal, R.
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
BAKILACAK
Source
Publisher
Elsevier
Subject
Oncology
Citation
Has Part
Source
Annals of Oncology
Book Series Title
Edition
DOI
10.1016/j.annonc.2022.07.1876
item.page.datauri
Link
Rights
N/A